Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
cvkd · market cap & enterprise value · FMP · as of Jun 9, 2026
Core market cap & key metrics
As of Jun 9, 2026, Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a market cap — also referred to as its net worth or valuation — of $12,233,073, making it one of the top most valuable companies globally. Market Cap = $4.27 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a market cap — also referred to as its net worth or valuation — of $12,233,073 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Cadrenal Therapeutics, Inc. Common Stock reached its all-time high market cap of $198,430,441.337 on Jan 20, 2023. Comparing the Cadrenal Therapeutics, Inc. Common Stock market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Cadrenal Therapeutics, Inc. Common Stock net worth vs peers and ask how Cadrenal Therapeutics, Inc. Common Stock valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
CVKD market cap · 6 questionsCadrenal Therapeutics, Inc. Common Stock's net worth — measured as market capitalization — is $12,233,073 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$4.27 (price) × shares outstanding.